A descriptive analysis of real-world treatment patterns of innovator (Remicade?) and biosimilar infliximab in an infliximab-na?ve Turkish population.
A descriptive analysis of real-world treatment patterns of innovator (Remicade?) and biosimilar infliximab in an infliximab-na?ve Turkish population. Biologics. 2018; 12:97-106.